Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Citi
Mallinckrodt
Cantor Fitzgerald
Dow
Novartis
US Army
Covington
Julphar
Express Scripts

Generated: February 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,703,017

« Back to Dashboard

Summary for Patent: 5,703,017
Title: 3-(Het) arylcarboxylic acid derivatives, their preparation and intermediates for their preparation
Abstract:3-(Het)arylcarboxylic acid derivatives of the formula I ##STR1## where R is formyl, CO.sub.2 H or a radical hydrolyzable to COOH and the other substituents have the following meanings: R.sup.2 and R.sup.3 are each halogen, alkyl, haloalkyl, alkoxy, haloalkoxy or alkylthio; X is nitrogen or CR.sup.14, where R.sup.14 is hydrogen or, together with R.sup.3, forms an alkylene or alkenylene chain, in each of which a methylene group is replaced by oxygen; R.sup.4 is phenyl or naphthyl, each of which is unsubstituted or substituted or an unsubstituted or substituted five-membered or six-membered heteroaromatic structure containing one to three nitrogen atoms or one sulfur or oxygen atom; R.sup.5 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, haloalkyl, alkoxyalkyl, alkylthioalkyl or phenyl; R.sup.6 is C.sub.1 -C.sub.8 -alkyl, C.sub.3 -C.sub.6 -alkenyl, C.sub.3 -C.sub.6 -alkynyl or C.sub.3 -C.sub.4 -cyclo-alkyl, each of which may be mono- or polysubstituted; Y is sulfur, oxygen or a single bond; and Z is sulfur or oxygen; with the proviso that R.sup.6 is not unsubstituted C.sub.1 -C.sub.4 -alkyl when R.sup.4 is unsubstituted phenyl, Z is oxygen and simultaneously R.sup.5 is methyl or hydrogen.
Inventor(s): Baumann; Ernst (Dudenhofen, DE), Rheinheimer; Joachim (Ludwigshafen, DE), Vogelbacher; Uwe Josef (Ludwigshafen, DE), Bratz; Matthias (Speyer, DE), Theobald; Hans (Limburgerhof, DE), Gerber; Matthias (Limburgerhof, DE), Westphalen; Karl-Otto (Speyer, DE), Walter; Helmut (Obrigheim, DE), Rademacher; Wilhelm (Limburgerhof, DE)
Assignee: BASF Aktiengesellschaft (Ludwigshafen, DE)
Application Number:08/537,843
Patent Claim Types:
see list of patent claims
Compound; Use; Process;

Drugs Protected by US Patent 5,703,017

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,703,017

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
GermanyP 43 13 412.2Apr 23, 1993
PCT Information
PCT FiledApril 13, 1994PCT Application Number:PCT/EP94/01141
PCT Publication Date:November 10, 1994PCT Publication Number: WO94/25442

International Patents Family Members for US Patent 5,703,017

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 214053 ➤ Sign Up
Australia 6568194 ➤ Sign Up
Australia 678236 ➤ Sign Up
Brazil 9406478 ➤ Sign Up
Canada 2160912 ➤ Sign Up
China 1066141 ➤ Sign Up
China 1121711 ➤ Sign Up
Czech Republic 291468 ➤ Sign Up
Czech Republic 9502768 ➤ Sign Up
Germany 4313412 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Cerilliant
Colorcon
Moodys
Merck
Harvard Business School
Fuji
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot